Kalehua Capital Management »

X4 Pharmaceuticals shares owned by Kalehua Capital Management

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Kalehua Capital Management from 13F filings

Historical chart of Kalehua Capital Management investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Kalehua Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Kalehua Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $15M 3.7M 4.13

More positions owned by Kalehua Capital Management

Alpha Architect 1-3 Month Box ETF Alpha Arch 1-3 (BOXX)
X4 Pharmaceuticals Com New (XFOR)
Surrozen Com New (SRZN)
Veradermics Common Stock
Relay Therapeutics (RLAY)
Sionna Therapeutics (SION)
Aclaris Therapeutics (ACRS)
Inhibikase Therapeutics Com New (IKT)
Oruka Therapeutics (ORKA)
Pharvaris N V (PHVS)
Uniqure NV SHS (QURE)
Septerna (SEPN)
Compass Pathways Sponsored Ads (CMPS)
Athira Pharma (LONA)
Damora Therapeutics Com New (DMRA)

View all positions for Kalehua Capital Management

Top funds holding X4 Pharmaceuticals

Morgan Stanley
Empery Asset Management
FMR
Bain Capital Life Sciences Investors
Perceptive Advisors
Deep Track Capital
Saturn V Capital Management
Kalehua Capital Management
Vanguard Capital Management
Vanguard Group
Braidwell
Blackstone Group
Rosalind Advisors
Trails Edge Capital Partners
Nantahala Capital Management

View all funds holding X4 Pharmaceuticals